BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31097920)

  • 1. CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy.
    Zhao J; Rui HL; Yang M; Sun LJ; Dong HR; Cheng H
    Mediators Inflamm; 2019; 2019():3172647. PubMed ID: 31097920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice.
    Li LC; Yang JL; Lee WC; Chen JB; Lee CT; Wang PW; Vaghese Z; Chen WY
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1720-F1731. PubMed ID: 30230367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 Promotes Podocyte Apoptosis by Activating the Pyrin Domain-Containing-3 (NLRP3) Inflammasome in Primary Nephrotic Syndrome.
    Yang X; Wu Y; Li Q; Zhang G; Wang M; Yang H; Li Q
    Med Sci Monit; 2018 Sep; 24():6832-6839. PubMed ID: 30258045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic 2X7 Receptor is Involved in the Podocyte Damage of Obesity-Related Glomerulopathy via Activating Nucleotide-Binding and Oligomerization Domain-Like Receptor Protein 3 Inflammasome.
    Hou XX; Dong HR; Sun LJ; Yang M; Cheng H; Chen YP
    Chin Med J (Engl); 2018 Nov; 131(22):2713-2725. PubMed ID: 30425198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.
    Xu X; Huang X; Zhang L; Huang X; Qin Z; Hua F
    BMC Nephrol; 2021 Jun; 22(1):218. PubMed ID: 34107901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD36 aggravates podocyte injury by activating NLRP3 inflammasome and inhibiting autophagy in lupus nephritis.
    Lv F; He Y; Xu H; Li Y; Han L; Yan L; Lang H; Zhao Y; Zhao Z; Qi Y
    Cell Death Dis; 2022 Aug; 13(8):729. PubMed ID: 35999224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
    Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of NLRP3 Inflammasome Activation and Inflammatory Exosome Release in Podocytes by Acid Sphingomyelinase During Obesity.
    Huang D; Kidd JM; Zou Y; Wu X; Gehr TWB; Li PL; Li G
    Inflammation; 2023 Oct; 46(5):2037-2054. PubMed ID: 37477734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
    Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17A participates in podocyte injury by inducing IL-1β secretion through ROS-NLRP3 inflammasome-caspase-1 pathway.
    Yan J; Li Y; Yang H; Zhang L; Yang B; Wang M; Li Q
    Scand J Immunol; 2018 Apr; 87(4):e12645. PubMed ID: 29446486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
    Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.
    Abais JM; Xia M; Li G; Chen Y; Conley SM; Gehr TWB; Boini KM; Li PL
    J Biol Chem; 2014 Sep; 289(39):27159-27168. PubMed ID: 25138219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation.
    Zhang Q; Conley SM; Li G; Yuan X; Li PL
    Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
    Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
    Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.
    Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK
    J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface-expression of LDLR and CD36 and NLRP3 inflammasome.
    Cyr Y; Lamantia V; Bissonnette S; Burnette M; Besse-Patin A; Demers A; Wabitsch M; Chrétien M; Mayer G; Estall JL; Saleh M; Faraj M
    Physiol Rep; 2021 Feb; 9(3):e14721. PubMed ID: 33527668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis.
    Fu R; Guo C; Wang S; Huang Y; Jin O; Hu H; Chen J; Xu B; Zhou M; Zhao J; Sung SJ; Wang H; Gaskin F; Yang N; Fu SM
    Arthritis Rheumatol; 2017 Aug; 69(8):1636-1646. PubMed ID: 28544564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coptidis Rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy.
    Ren Y; Wang D; Lu F; Zou X; Xu L; Wang K; Huang W; Su H; Zhang C; Gao Y; Dong H
    Phytomedicine; 2018 Oct; 49():52-65. PubMed ID: 30217262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.
    Li G; Chen Z; Bhat OM; Zhang Q; Abais-Battad JM; Conley SM; Ritter JK; Li PL
    J Lipid Res; 2017 Jun; 58(6):1080-1090. PubMed ID: 28404641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.